Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SurfStab I: 1-Minute vs 5-Minute Surfactant Administration in Very Preterm Neonates
NCT07261787Phase 4Recruiting
- Sponsor
- Medical University of Graz
- Start
- Feb 2026
- Primary completion
- Jul 2028
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Poractant alfa in respiratory distress syndrome (RDS), sponsored by Medical University of Graz. Started Feb 2026; status: recruiting.
02
Drugs
Poractant alfa
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on NCT07261787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07261787.